About Maria Vivaldi, MD

Maria T. Vivaldi, MD, FACC is a clinical cardiologist and staff physician at the Corrigan Women's Heart Health Program and the Cardiac Ultrasound Laboratory at the Massachusetts General Hospital's Corrigan Minehan Heart Center in Boston. She is also an Assistant Professor at the Harvard Medical School. Dr Vivaldi completed her fellowship in clinical cardiology at Brigham and Women's Hospital, followed by a fellowship in echocardiography at Mass General. Dr. Vivaldi is currently the Director of Education of the Corrigan Women’s Heart Health Program. She has been recognized for her teaching and has received the Harvard Danforth Award for Excellence in Teaching. She also received the Pierre Moussa Fellow Award for her interest in cardiovascular research. She is a Councilor of the Massachusetts Chapter, American College of Cardiology and serves as co-chair of Women in Cardiology, Massachusetts Chapter, ACC.

Her current research endeavors span a wide spectrum of cardiac prevention and include serving as co-investigator for the ORION 9/10 Project which focuses on a novel PCSK9i research examining the effects of Lipoprotein A on ASCVD, Hypertension during pregnancy and the postpartum period, and utilization of an mHealth platform to manage a post PCI population.

Beyond her clinical practice, Dr. Vivaldi has championed and advocated for improved awareness and education of women concerning heart disease and cardiovascular risk factors through her involvement in the American Heart Association's Circle of Red. In her capacity as Chair of the Circle of Red, she has worked diligently to support their mission of preventing and reducing the prevalence of heart disease in women. Dr. Vivaldi is trilingual and has a special interest in cardiac disease in Latino women and has been a faculty member of the Massachusetts Medical Society's lecture series, Ethnic Differences in Cardiovascular Disease. Her clinical interests include Women's Heart Disease, Cardiac Ultrasound and Preventive Cardiology and she maintains a robust practice at 3 distinct MGH clinical sites- the Cardiovascular Medicine Clinic, the Cardiovascular Disease Prevention Center as well as the Revere Health Center. 

Clinical Interests:

Treats:

Languages:

Locations

Mass General Heart Center
55 Fruit St.
Boston, MA 02114
Phone: 866-644-8910

Medical Education

  • MD, Universidad De Concepcion - Chile
  • Fellowship, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Cardiovascular Disease, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Research interests have included acute coronary syndromes and experimental studies on limiting/reducing infarct size through pharmacological means, with particular emphasis on drugs that modify myocardial infarct healing. She also has studied and developed methods to accurately quantify the size of myocardial infarcts enabling to measure the influence of drugs on collagen formation after myocardial infarction.

Dr Vivaldi's clinical research interest focuses on valvular heart disease, including long term follow up of mitral valve prolapse assessing different endpoints such as hospitalization, mortality and need for mitral valve surgery. Using echocardiography she has also prospectively studied a population of patients with trace aortic insufficiency to understand the natural history of the disease and determine appropriate clinical interventional points.

Publications

  • Select Publications:

    • Vivaldi MT, Eyre D, Kloner RA, Schoen,FJ. Effects of methylprednisolone on collagen biosynthesis in healing AMI. Am J Cardiol 1987; 60: 424-425
    • Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol 1985; 121: 522-530
    • Padial LR, Oliver A, Vivaldi M, Sagie A, Freitas N, Weyman A, Levine R.Doppler Echo assessment of progression of AR. Am J Cardiol 1997; 80: 306-314

Reviews: Comments and Ratings